Stay updated on Tiragolumab Combo in Stage II Melanoma Clinical Trial
Sign up to get notified when there's something new on the Tiragolumab Combo in Stage II Melanoma Clinical Trial page.

Latest updates to the Tiragolumab Combo in Stage II Melanoma Clinical Trial page
- CheckyesterdayChange DetectedThe page’s interface/update footer changed from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a site version update. No clinical trial record details were shown to be added or removed in the displayed content.SummaryDifference0.1%

- Check8 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check37 days agoChange DetectedAdded revision v3.5.0 to the history and removed revision v3.4.3.SummaryDifference0.1%

- Check44 days agoChange DetectedRevision history now includes the addition of v3.4.3 and removal of v3.4.2.SummaryDifference0.1%

- Check73 days agoChange DetectedAdded Revision: v3.4.2 to the record history. Removed the old funding notice and Revision: v3.4.1.SummaryDifference0.8%

- Check80 days agoChange DetectedAdded a site-wide notice about a lapse in government funding that may affect updates, processing, and responses, with guidance to check status. Updated the revision version to v3.4.1.SummaryDifference0.9%

Stay in the know with updates to Tiragolumab Combo in Stage II Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tiragolumab Combo in Stage II Melanoma Clinical Trial page.